Vancoresmycin, a process for its production and its use as a pharmaceutical

US6387943B1 · kind B1 · utility

Assignee

• Aventis Pharma Deutschland GmbH · DE

Inventors

• Nirogi Venkata Satya Ramakrishna · Hyderabad, IN
• Ravi Gajanan Bhat · Mumbai, IN
• Eyyammadichiyil Sankaranarayanan Sreekumar · Jamkhed, IN
• Erra K. S. Vijayakumar · Yellandu, IN
• Shantilal Dayaram Naker · Mumbai, IN
• Uttara Vinayak Oak · Jamkhed, IN
• Rajendra P. TANPURE · Jamkhed, IN
• Cordula Hopmann · Berlin, DE
• Michael Kurz · Neustadt, DE
• Joachim Wink · Rödermark, DE
• Gerhard Seibert · Darmstadt, DE
• Dominique Le Beller · Compiègne, FR
• Jozsef Aszodi · Choisy-le-Roi, FR

Key dates

• Filing date: Nov 9, 1999
• Grant date: May 14, 2002
• Expiry date: Nov 9, 2019

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12P19/44
• WIPO field: Biotechnology
• WIPO sector: Chemistry

Abstract

The present invention relates to a compound named Vancoresmycin which is obtainable by cultivation of the microorganism HIL-006734 (DSM 12216), and to its pharmaceutically acceptable salts. The present invention further relates to a process for the production of Vancoresmycin, to the microorganism HIL-006734 (DSM 12216), to the use of Vancoresmycin and its pharmaceutically acceptable salts as pharmaceuticals, and in particular to their use as antibiotics, and to pharmaceutical compositions comprising Vancoresmycin or a pharmaceutically acceptable salt thereof.